Caspar Foghsgaard

Caspar Foghsgaard has extensive work experience in various roles and companies within the biopharmaceutical and business development sectors. Caspar currently serves as the Sr. VP Commercial and Business Development at EXACT Therapeutics. Prior to this, they co-founded Scipio Bioscience and held the role of Chairman of the Board of Directors at Stella Nova Copenhagen A/S. Caspar also served as a Member of the Board of Directors at Labflex Holding A/S and ST Skoleinventar A/S. Caspar Foghsgaard has held several roles at Nykode Therapeutics, including Sr. Director, Special Projects and Director, Business Development. Caspar was also the Head of Business Development, Spirits division at Arcus AS and a Member of the Board of Directors at ArcusGruppen AS. Furthermore, they worked as an Investment Committee Member at Credo Partners, specializing in the acquisition of Globus Wine A/S. Caspar Foghsgaard also founded their own consulting firm, C. Foghsgaard Consulting.

Caspar Foghsgaard's education history includes a BSc (Honours) degree in Chemistry with Biological Chemistry from the University of St Andrews, completed from 1997 to 2001. Caspar then pursued an MSc degree in Management from the University of Surrey in 2003. Additionally, Caspar participated in various professional development courses and seminars, including those focused on leadership, negotiation skills, media training, business marketing strategy, and achieving outstanding performance. In 2021, they completed The Pharma Brand Planning Course at CELforPharma. In 2023, Caspar attended Atrium Copenhagen to gain an understanding of health economic analyses.